Xuan Yu Mao

Title: Xuan Yu Mao: Innovator in Breast Cancer Prognostics

Introduction

Xuan Yu Mao is a prominent inventor based in Moraga, California. He has made significant contributions to the field of cancer research, particularly in developing prognostic tools for breast cancer survival. His innovative work focuses on utilizing genetic biomarkers to improve patient outcomes.

Latest Patents

Xuan Yu Mao holds a patent for a "12-gene prognostic signature for breast cancer survival." This patent describes a biomarker panel consisting of 12 genes based on their expression levels. The methods outlined in the patent include calculating prognostic scores and ranking patients based on these scores, which are divided into two equal-sized cohorts. The effectiveness of this approach was validated using Kaplan-Meier analysis and a log-rank test to determine differences in survival rates.

Career Highlights

Xuan Yu Mao is affiliated with the University of California, where he continues to advance research in the field of oncology. His work has the potential to significantly impact how breast cancer is diagnosed and treated, providing valuable insights into patient prognostics.

Collaborations

Xuan Yu Mao has collaborated with notable colleagues, including Antoine M Snijders and Matthew J Lee. These partnerships have fostered a collaborative environment that enhances the research and development of innovative cancer treatments.

Conclusion

Xuan Yu Mao's contributions to breast cancer research through his patented innovations exemplify the importance of genetic biomarkers in improving patient care. His work continues to pave the way for advancements in cancer prognostics and treatment strategies.